By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Could Orphan Drugs Turn Health Economics on its Ear?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Health Reform > Could Orphan Drugs Turn Health Economics on its Ear?
DiagnosticsHealth ReformMedical InnovationsNewsTechnology

Could Orphan Drugs Turn Health Economics on its Ear?

Kenneth Walz
Kenneth Walz
Share
2 Min Read
SHARE

When is $100,000 a year more expensive than $500,000 a year? The answer: when developing drugs to treat common diseases (e.g., cancer) rather than rare diseases. According to a new article in Forbes magazine, governments and insurers are willing to pay upwards of $200,000 and as much as $500,000 for new orphan drug treatments that attack rare diseases (usually caused by a single gene).

When is $100,000 a year more expensive than $500,000 a year? The answer: when developing drugs to treat common diseases (e.g., cancer) rather than rare diseases. According to a new article in Forbes magazine, governments and insurers are willing to pay upwards of $200,000 and as much as $500,000 for new orphan drug treatments that attack rare diseases (usually caused by a single gene). Since people suffering from these diseases have a known genetic profile, these targeted treatments are far more effective than most cancer drugs, for which insurers will usually cover up to $100,000 per patient per year.

National Institutes of Health (NIH) Director Francis Collins is urging companies to find more treatments for rare diseases. Of the 7,000 diseases that affect humans worldwide, 6,000 are rare. Traditional drug discovery and development methods for mass populations won’t be effective against these diseases. But more targeted approaches, with specific biologics and companion diagnostics, could be.

What do you think? Are companies like Agios a flash in the pan? Does $500,000 a year per patient sound like a viable pricing strategy? Are orphan diseases and drugs to treat them the future of medicine? Share your thoughts with us.

More Read

Personalized Medicine and a Cure for Cancer
Good Riddance to Routine Pelvic Examinations
One Week Into the Heart of the ACA
How to Leverage Web 2.0 Through Content Management Systems for Hospitals and Practice Websites
Breath Tests Could Reveal Clues About Cancer, Heart Failure, Diabetes

 


TAGGED:cancer drugscancer treatmentdrug developmentorphan drugstargeted treatment
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

What to Look for in IT Compliance Solutions for Health Care Providers
What to Look for in IT Compliance Solutions for Health Care Providers
Global Healthcare Policy & Law
September 24, 2025
male doctor massaging shoulders of patient
A 6-Step Guide to Physiotherapy for Sports Injuries
Therapy
September 24, 2025
Breaking Mental Health Stigma
The Importance of Breaking Mental Health Stigma in 2025
Mental Health
September 23, 2025
scientist using microscope
Considerations for Sourcing PCR Primers for your Healthcare Project
Health
September 20, 2025

You Might also Like

First Treatments Completed for Parkinson’s Disease Study Sponsored by the Focused Ultrasound Foundation

October 24, 2012
health insurance costs 2023
News

What Factors Impact Health Insurance Costs in 2023?

April 10, 2023

Telehealth: Interview with Roy Schoenberg, CEO of American Well

June 11, 2014

Conference Season Approaching – Prepare for Landing

August 8, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?